SBIR/STTR Research Award

Pediatric Implantable Low-Shear Pulsatile Blood Pump with Physiologic Sensing and Control

Award identifier 7fb0f53dea904ff76663f79168872d61efee06513f22e52fa9134284b21053aeAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$223,999

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
WINDMILL CARDIOVASCULAR
Proposal award date
2018-08-06
Contract end date
2019-01-31
UEI
DCM2TK5ZRKK6
Solicitation number
PA17-302
Topic code
NHLBI

Research abstract

Project SummaryAbstract The goal of this project is to develop high level physiological controlimprove low level dynamic piston controland develop hemodynamic sensing capabilities for the pediatric TORVADTMa unique ventricular assist system that delivers low shearsynchronouspulsatile flowusing controlled piston motion within a torus shaped pumping chamberThe pediatric TORVAD is intended for patients with a body surface area fromtombut the design can be scaled to adapt to a wide variety of patient sizes and needsLow shear in the pumped blood is managed by the relatively low speed of the pistons which are supported by hydrodynamic bearings that maintain a fixed piston torus gapThe primary operating mode delivers amL counterpulse ejectionbut the pump can also operate asynchronously to deliver full cardiac support up toL minThe system synchronizes with the heart to preserve aortic valve flow and maintains autoregulation of cardiac output by the Frank Starling mechanismThe design of the TORVAD also enables determination of differential pump pressurewithout additional sensorsThis inherent sensing capability can be used to inform patient medications and optimal pump supportThese device advantages have been confirmed in benchtop studies and acute and chronic animal experiments with an adult TORVADand results have indicated preservation of high molecular weight von Willebrand FactorThe pediatric TORVAD has been designed to exhibit these same advantagesand thus has the potential to reduce bleedingthrombus formationand strokes that are associated with the use of other pediatric ventricular assist devicesSpecific aims for Phase I areImprove the dynamic piston controlImplement dynamic pressure sensing during pump actuationandDevelop systemic vascular resistanceSVRestimationSpecific aims for Phase II areImplement physiologic control of VAD flowFabricate devices for acute and chronic animal experimentsPerform four acute animal studies to assess control algorithmspressure signal sensingand SVR estimationPerform six chronic animal studies to assess long term viability of the pediatric TORVAD and algorithms Project Narrative Clinicians are commonly faced with a life sustaining struggle between an increasing need for mechanical circulatory support in pediatric patients but devices with outcomes that are sub optimalComplications related to currently available pediatric circulatory support devices are devastatingand serious adverse event rates associated with these devices are unacceptably highThe pediatric TORVAD has the potential to significantly reduce the complications associated with ventricular assist devices including the incidence of major bleedingneurological dysfunctionand strokesits success will provide beneficial patient outcomes and allow for more widespread as well as longer term use of ventricular assist devices in pediatric patients

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2013–2019). Reported award amounts total $6,565,818. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.